Final Results of a Phase II Study of Sunitinib As Second Line Therapy of Malignant Pleural Mesothelioma (MPM)

A. K. Nowak, R. J. Francis, M. J. Millward, A. van der Schaaf, T. Seguard, J. Creaney, A. Hasani, A. W. Musk, M. J. Byrne

Research output: Contribution to journalAbstract/Meeting Abstractpeer-review

Original languageEnglish
Pages (from-to)S12-S12
Number of pages1
JournalJournal of Thoracic Oncology
Issue number3
Publication statusPublished - Mar 2011
Event3rd Australian Lung Cancer Conference (ALCC) - Melbourne, Australia
Duration: 7 Oct 20109 Oct 2010

Cite this